Skip to main content
SpringerLink
Log in

Occurrence and relevance of chemically induced benign neoplasms in long-term carcinogenicity studies

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Recent carcinogenicity studies conducted and evaluated by the National Toxicology Program/National Institute of Environmental Health Sciences were examined to determine the frequency of chemically increased incidences of neoplasia. Many of the chemicals originally selected for study were chosen because of an a priori suggestion that they might be carcinogens. Of the 143 chemical studies evaluated, usually involving male and female rats and mice, 42 (29%) did not induce any neoplasms, 20 (14%) gave marginal or equivocal neoplastic responses, and 81 (57%) showed positive neoplastic responses in one or more of the 524 species-gender experiments. Of these 81 positive studies, 60 (74%) were considered positive based on malignant neoplasia, 16 (20%) were positive due primarily to benign neoplasia, but hd supporting evidence of malignant neoplasia in the same organ/tissue, and 5 (6%) were positive based only on benign neoplasia. These five chemicals are a) allyl isothiocyanate (transitional cell papillomas of the urinary bladder in male rats), b) 2-amino-4-nitrophenol (tubular cell adenomas of the kidney in male rats), c) asbestos intermediate range chrysotile (adenomatous polyps of the large intestine in male rats), d) decabromodiphenyl oxide (neoplastic nodules of the liver in male and female rats), and e) nitrofurazone (fibroadenomas of the mammary gland in female rats and benign mixed tumors and granulosa cell tumors of the ovary in female mice). For all but one of these lesions (mammary gland), the occurrence in historic controls is low. Thus, only 5 of the 143 chemicals studied (3.5%) induced benign neoplasia alone, and those observed benign neoplasms are known to progress to malignancy. Accordingly, we consider chemically induced benign neoplasia to be an important indicator of a chemical's carcinogenic potential in rodents, and believe it should continue to be made an integral part of the overall weight-of-the evidence evaluation process for identifying potential human health hazards.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. National Cancer Advisory Board: General criteria for assessing the evidence for the carcinogenicity of chemical substances: Report of the Subcommittee on Environmental Carcinogenesis. JNCI 58: 461–465, 1977

    Google Scholar 

  2. American Industrial Health Council (AIHC): Interdisciplinary panel on carcinogenicity. Criteria for evidence of chemical carcinogenicity. Science 225: 682–687, 1984

    Google Scholar 

  3. Office of Science and Technology Policy (OSTP): Chemical carcinogens: A review of the science and its associated principles. Interagency Staff Group on Chemical Carcinogenesis. Fed Reg 50: 10371–10442, 1984

    Google Scholar 

  4. IARC: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volumes 1–42, 1978–1988. International Agency for Research on Cancer, Lyon, France

    Google Scholar 

  5. IARC: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall evaluations of carcinogenicity: An updating of IARC Monographs Volumes 1 to 42, Supplement 7, 1–440, 1987. International Agency for Research on Cancer, Lyon, France

    Google Scholar 

  6. Ward JM: Pathology of toxic, preneoplastic, and neoplastic lesions. In: Douglas JF (ed) Carcinogenesis and Mutagenesis Testing. The Humana Press, Clifton, NJ, 1984, pp 97–130

    Google Scholar 

  7. Environmental Protection Agency: Intent to review guidelines for carcinogen risk assessment. Fed Reg 53: 32656–32658, 1988

    Google Scholar 

  8. Huff JE: Carcinogenesis bioassay results from the National Toxicology Program. Environ Health Perspect 45: 185–198, 1982

    Google Scholar 

  9. Ad Hoc Panel: Report of the Ad Hoc Panel on Chemical Carcinogenesis Testing and Evaluation. Presented to the National Toxicology Program Board of Scientific Counselors. National Toxicology Program, Research Triangle Park, NC, 280 pages, 1984

    Google Scholar 

  10. Haseman JK, Crawford DD, Huff JE, Boorman GA, McConnell EE: Results from 86 two-year carcinogenicity studies conducted by the National Toxicology Program. J Toxicol Environ Health 14: 621–639, 1984

    Google Scholar 

  11. Huff JE, Haseman JK, McConnell EE, Moore JA: The National Toxicology Program, toxicology data evaluation techniques, and long-term carcinogenesis studies. In: Lloyd WE (ed) Safety Evaluation of Drugs and Chemicals 28. Hemisphere Publishing Company, Washington, D.C., 1986, pp 411–447

    Google Scholar 

  12. Haseman JK, Huff JE, Zeiger E, McConnell EE: Comparative results of 327 chemical carcinogenicity studies. Environ Health Perspect 74: 229–235, 1987

    Google Scholar 

  13. Huff JE, McConnell EE, Haseman JK, Boorman GA, Eustis SL, Schwetz BA, Rao GN, Jameson CW, Hart LG, Rall DP: Carcinogenesis studies: Results of 398 experiments on 104 chemicals from the U.S. National Toxicology Program. Ann New York Acad Sciences 534: 1–30, 1988

    Google Scholar 

  14. NTP: NTP Fiscal Year 1988 Annual Plant, National Toxicology Program, Research Triangle Park, NC, 1987, 343 pages

    Google Scholar 

  15. Griesemer RA, Cueto C: Toward a classification scheme for degrees of experimental evidence for the carcinogenicity of chemicals for animals. In: Montesano D, Bartsch H, Tomatis L (eds) Molecular and Cellular Aspects of Carcinogen Screening Tests. IARC Scientific Publications 27, International Agency for Research on Cancer, Lyon, France, 1980, pp 259–281

    Google Scholar 

  16. Chu KC, Cueto C, Ward JM: Factors in the evaluation of 200 National Cancer Institute carcinogen bioassays. J Toxicol Environ Health 8: 251–280, 1981

    Google Scholar 

  17. Maronpot RR, Haseman JK, Boorman GA, Eustis SE, Rao GN, Huff JE: Liver lesions in B6C3F1 mice: The National Toxicology Program experience and position. Arch Toxicol Supl 10: 10–26, 1987

    Google Scholar 

  18. Hoel DG, Haseman JK, Hogan MD, Huff JE, McConnell EE: The impact of toxicity on carcinogenicity studies: Implications for risk assessment. Carcinogenesis 9: 2045–2052, 1988.

    Google Scholar 

  19. Alden CJ, Huff JE: Guidelines for the preparation of NTP Technical Reports on toxicology and carcinogenesis studies. National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, 64 pages, 1984

    Google Scholar 

  20. Huff JE: Carcinogenesis bioassay of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (CAS No. 2746–01–6) in Osborne-Mendel rats and B6C3F1 mice (gavage studies). Technical Report No. 209, National Toxicology Program, Research Triangle Park, NC, 195 pages, 1982

    Google Scholar 

  21. Kari F: Toxicology and carcinogenesis studies of Hydroquinone (CAS No. 123–31–9) in F344 rats and B6C3F1 mice (gavage studies). Technical Report No. 366, National Toxicology Program, Research Triangle Park, NC, 134 pages, 1989

    Google Scholar 

  22. Mennear J: Toxicology and carcinogenesis studies of dichloromethane (methylene chloride) (CAS No. 75–09–2) in F344/N rats and B6C3F1 mice (inhalation studies). Technical Report No. 306, National Toxicology Program, Research Triangle Park, NC, 208 pages, 1986

    Google Scholar 

  23. Mennear JH, McConnell EE, Huff JE, Renne RA, Giddens E: Inhalation toxicology and carcinogenesis studies of methylene chloride (dichloromethane) in F344/N rats and B6C3F1 mice. Ann New York Acad Sciences 534: 343–351, 1988

    Google Scholar 

  24. French J: Toxicology and carcinogenesis studies of chlorendic acid in F344/N rats and B6C3F1 mice (feed studies). Technical Report No. 304, National Toxicology Program, Research Triangle Park, NC, 233 pages, 1987

    Google Scholar 

  25. Rall DP, Hogan MD, Huff JE, Schwetz BA, Tennant RW: Alternatives to using human experience in assessing health risks. Ann Rev Public Health 8: 355–385, 1987

    Google Scholar 

  26. Irwin R: Carcinogenesis bioassay of C.I. solvent yellow 14 (CAS No. 842–07–9) in F344/N rats and B6C3F1 mice (feed study). Technical Report No. 226, National Toxicology Program, Research Triangle Park, NC, 163 pages, 1982

    Google Scholar 

  27. Haseman JK, Huff JE, Rao GN, Arnold JE, Boorman GA, McConnell EE: Neoplasms observed in untreated and corn oil gavage control groups of F344/N rats and (C57BL/6N x C3H/HeN)F1 mice. JNCI 75: 975–984, 1985

    Google Scholar 

  28. Huff JE: Carcinogenesis bioassay of 2,6-dichloro-p-phenylenediamine (CAS No. 609–20–1) in F344 rats and B6C3F1 mice (feed study). Technical Report No. 219, National Toxicology Program, Research Triangle Park, NC, 121 pages, 1982

    Google Scholar 

  29. McConnell EE, Solleveld HA, Swenberg JA, Boorman GA: Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. JNCI 76 (2): 283–289, 1986

    Google Scholar 

  30. Dunnick J: Carcinogenesis bioassay of Allyl Isothiocyanate (CAS No. 57–06–7) in F344/N rats and B6C3F1 mice (gavage study). Technical Report No. 234, National Toxicology Program, Research Triangle Park, NC, 182 pages, 1982

    Google Scholar 

  31. Dunnick JD, Prejean JD, Haseman JK, Thompson RB, Giles D, McConnell EE: Carcinogenesis bioassay of allyl isothiocyanate. Fundament Appl Toxicol 2: 114–120, 1982

    Google Scholar 

  32. Ioannou YM, Burka LT, Matthews HB: Allyl isothiocyanate: Comparative disposition in rats and mice. Toxicol Appl Pharmacol 75: 173–181, 1984

    Google Scholar 

  33. Irwin RD: Carcinogenesis studies of 2-Amino-4-nitrophenol (CAS No. 99–57–0) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report No. 339, National Toxicology Program, Research Triangle Park, NC, 170 pages, 1988

    Google Scholar 

  34. Irwin R, Bishop J, Huff JE: Comparative toxicity and carcinogenicity of three isomerica amino-nitrophenols, Unpublished observations. Paper in preparation

  35. McConnell EE: Toxicology and carcinogenesis studies of chrysotile asbestos in F344/N rats (feed studies). Technical report No. 295, National Toxicology Program, Research Triangle Park, NC, 390 pages, 1985

    Google Scholar 

  36. Matthews HB: Toxicology and carcinogenesis studies of decabromodiphenyl oxide in F344/N rats and B6C3F1 mice (feed studies). Technical report No. 309, National Toxicology Program, Research Triangle Park, NC, 242 pages, 1986

    Google Scholar 

  37. Kari F: Toxicology and carcinogenesis studies of nitrofurazone (CAS No. 59–87–0) in F344/N rats and B6C3F1 mice (Feed studies). Technical Report No. 337, National Toxicology Program, Research Triangle Park, NC, 183 pages, 1988

    Google Scholar 

  38. Kari F, Huff J, Leininger J, Haseman J, Eustis S: Toxicity and carcinogenicity of nitrofurazone in F344/N rats and B6C3F1 mice. Food Chem Tox, In Press 1989

  39. Weisburger EK: History of the bioassay program of the National Cancer Institute. Prog Exp Tumor Res 26: 187–201, 1983

    Google Scholar 

  40. NCI: Bioassay of 2,4-dinitrotoluene for possible carcinogenicity. Technical Report No. 54, National Cancer Institute, Bethesda, MD, 78 pages, 1978

    Google Scholar 

  41. NCI: Bioassay of 2-nitro-p-phenylenediamine for possible carcinogenicity. Technical Report No. 169, National Cancer Institute, Bethesda, 82 pages, 1979

    Google Scholar 

  42. Prehn RT, Prehn LM: Pathobiology of neoplasia. Amer J Pathol 80 (3): 529–550, 1975

    Google Scholar 

  43. Farber E, Cameron R: The sequential analysis of cancer development. Adv Can Res 31: 125–226, 1980

    Google Scholar 

  44. Pitot HC: The stability of events in the natural history of neoplasia. Amer J Pathol 89 (3): 703–715, 1977

    Google Scholar 

  45. Department of Labor: Identification, classification and regulation of potential occupational carcinogens. Fed Reg 45 (15): 5001–5296, 1980

    Google Scholar 

  46. Nowell PC: Mechanisms of tumor progression. Cancer Res 46: 2203–2207, 1986

    Google Scholar 

  47. Sasaki T, Yoshida T: Liver carcinoma induced by feeding o-amidoazotoluene (from German). Virch Archiv Pathol Anat 295: 175–220, 1935

    Google Scholar 

  48. Bannasch P: Sequential cellular changes during chemical carcinogenesis. J Cancer Res Clin Oncol 108: 11–22, 1984

    Google Scholar 

  49. Farber E: The multistep nature of cancer development. Cancer Res 44: 4217–4223, 1984

    Google Scholar 

  50. Medina D, Kittrell FS: Enhancement of tumorigenicity with morphological progression in a BALB/c preneoplastic outgrowth line. JNCI 79 (3): 569–576, 1987

    Google Scholar 

  51. Van Zwieten M: Correlation of mammary tumor histology with experimental procedures In: The rat as animal model in breast cancer research. A histopathological study of radiation- and hormone-induced rat mammary tumors. The Netherlands: Martinus Nijhoff Publishers, pp 135–158, 1984

    Google Scholar 

  52. Wilson J, Boorman G, Eustis S: Carcinoma arising in fibroadenoma of the F344/N rat. Unpublished observations, paper in preparation.

  53. Erturk E, Morris JE, Cohen SM, Price JM, Bryan GT: Transplantable rat mammary tumors induced by 5-nitro-2-furaldehyde semicarbazone and by formic acid 2-[4-(5-nitro-2-furyl)-2- thiazolyl]hydrazide. Cancer Res 30: 1409–1412, 1970

    Google Scholar 

  54. Koss LG: Tumors of the urinary bladder. Fascicle 11, second series, Atlas of Tumor Pathology, Armed Forces Institute of Pathology, Washington, D.C., 1975

    Google Scholar 

  55. Scully RE: Tumors of the ovary and maldeveloped gonads. Fascicle 16, second series, Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, D.C., 1979

    Google Scholar 

  56. Turusov VS: Pathology of tumours in laboratory animals. (ed) Vol. I — Tumours of the Rat, Part 1. International Agency for Research on Cancer, Lyon, France, IARC Scientific Publications 5: 212 pages, 1973

    Google Scholar 

  57. Turusov VS: Pathology of tumours in laboratory animals. (ed) Vol. I — Tumours of the Rat, Part 2. International Agency for Research on Cancer, Lyon, France, IARC Scientific Publications 6: 319 pages, 1976

    Google Scholar 

  58. Turusov VS: Pathology of tumours in laboratory animals. (ed) Vol. II — Tumours of the Mouse. International Agency for Research on Cancer, Lyon, France, IARC Scientific Publications 23: 669 pages, 1979

    Google Scholar 

  59. Turusov VS: Pathology of tumours in laboratory animals. (ed) Vol. III — Tumours of the Hamster. International Agency for Research on Cancer, Lyon, France, IARC Scientific Publications 34: 462 pages, 1982

    Google Scholar 

  60. Teebor GW, Becker FF: Regression and persistence of hyperplastic hepatic nodules induced by N-2-fluorenylacetamide and their relationship to hepatocarcinogenesis. Cancer Res 31: 1–3, 1971

    Google Scholar 

  61. Diwan BA, Ward JM, Henneman J, Wenk ML: Effects of short-term exposure to the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate on skin carcinogenesis in Sencar mice. Cancer Letters 26: 177–184, 1985

    Google Scholar 

  62. Huff JE, Moore JA: Carcinogenesis studies design and experimental data interpretation/evaluation at the National Toxicology Program. In: Jarvisalo J, Pfaffli P, Vainio H (eds) Industrial Hazards of Plastics and Synthetic Elastomers. Alan R. Liss, Inc., New York, pp 43–64, 1984

    Google Scholar 

  63. Rall DP: National Toxicology Program (NTP): Levels of evidence of carcinogenicity used to describe evaluative conclusions for NTP long-term toxicology and carcinogenesis studies; request for comments. Fed Reg 51: 2579–2582, 1986

    Google Scholar 

  64. Rall DP: National Toxicology Program (NTP): Notice of modifications in the levels of evidence of carcinogenicity used to describe evaluative conclusions for NTP long-term toxicology and carcinogenesis studies. Fed Reg 51: 11843–11844, 1986

    Google Scholar 

  65. Hicks RM, Chowaniee J: Experimental induction, histology, and ultrastructure of hyperplasia and neoplasia of the urinary bladder epithelium. Internat Rev Exp Pathol 18: 199–280, 1978

    Google Scholar 

  66. Lane N, Fenoglio CM, Kaye GI, Pascal RR: Defining the precursor tissue of ordinary large bowel carcinoma: Implications for cancer prevention. In: Lipkin M, Good R (eds) Gastrointestinal Tract Cancer. Plenum Publ Corp, New York, pp 295–324, 1978

    Google Scholar 

  67. Maronpot RR, Boorman GA: Interpretation of rodent hepatocellular proliferative alterations and hepatocellular tumors in chemical safety assessment. Toxicol Pathol 10: 71–80, 1982

    Google Scholar 

  68. Nutrition Foundation: The relevance of mouse liver hepatoma to human carcinogenic risk. The Nutrition Foundation, Washington, D.C., 34 pages, 1983

    Google Scholar 

  69. Popp JA (ed): Potential use of initiation-promotion studies in understanding mouse liver neoplasia. In: Mouse Liver Neoplasia: Current Perspectives, Hemisphere Publishing Co., Washington, D.C., 184 pages, 1984

    Google Scholar 

  70. Maronpot RR, Montgomery CAJr, Boorman GA, McConnell EE: National Toxicology Program nomenclature for hepatoproliferative lesions of rats. Toxicol Pathol 14 (2): 263–273, 1986

    Google Scholar 

  71. Quintanilla M, Brown K, Ramsden M, Balmain A: Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature (London) 322: 78–80, 1986

    Google Scholar 

  72. Reynolds SH, Stowers SJ, Maronpot RR, Anderson MW, Aaronson SA: Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. Proc Natl Acad Sci, USA 83: 33–37, 1986

    Google Scholar 

  73. Reynolds SH, Stowers SJ, Patterson R, Maronpot RR, Aaronson SA, Anderson MW: Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science 237: 1309–1316

  74. Anderson MW, Reynolds SH: Activation of oncogenes by chemical carcinogens. In: Sirica AE (ed) The Pathobiology of Neoplasia. Plenum Press, in press

  75. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293–297, 1987

    Google Scholar 

  76. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327: 298–303, 1987

    Google Scholar 

  77. Owen PE, Glaister JR, Gaunt IF, Pullinger DH: Inhalation toxicity studies with 1,3-butadiene. 3. Two-year toxicity/carcinogenicity study in rats. Am Ind Hyg Assoc J 48: 407–413, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Toxicology Program, National Institute of Environmental Health Sciences, 27709, Research Triangle Park, North Carolina, USA

    J. E. Huff, S. L. Eustis & J. K. Haseman

Authors
  1. J. E. Huff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. L. Eustis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. K. Haseman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huff, J.E., Eustis, S.L. & Haseman, J.K. Occurrence and relevance of chemically induced benign neoplasms in long-term carcinogenicity studies. Cancer Metast Rev 8, 1–21 (1989). https://doi.org/10.1007/BF00047055

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00047055

Key words

Search

Navigation